Back to LYEL
BRIDGEWAY CAPITAL MANAGEMENT, LLC → LYEL
BRIDGEWAY CAPITAL MANAGEMENT, LLC LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
4
Latest value
$246K
Q3 2026
Peak value
$554K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $554K |
| Q1 2026 | $361K |
| Q2 2026 | $253K |
| Q3 2026 | $246K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $246K | 25.2K | — | — |
| Q2 2026 | $253K | 18.0K | — | — |
| Q1 2026 | $361K | 18.0K | — | — |
| Q4 2025 | $554K | 18.0K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M